Our findings suggest that PD‐DCIS and PD‐IDC have poor tumor characteristics, including high‐histological grades, advanced AJCC stages, low HR‐positive ratios, and high HER2‐positive ratios. This evidence concerns the gene ERBB2 and ductal breast carcinoma in situ.